These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6739223)

  • 21. Impermeability of the blood-cerebrospinal fluid barrier to 1-deamino-8-D-arginine-vasopressin (DDAVP) in patients with acquired, communicating hydrocephalus.
    Sørensen PS; Vilhardt H; Gjerris F; Warberg J
    Eur J Clin Invest; 1984 Dec; 14(6):435-9. PubMed ID: 6441719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma concentrations of 1-deamino-8-D-arginine vasopressin after intragastric administration in the rat.
    Lundin S; Melin P; Vilhardt H
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):179-83. PubMed ID: 3969814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of arginine vasopressin suppression of ovine fetal lung fluid secretion: lack of V2-receptor effect.
    Albuquerque CA; Nijland MJ; Ross MG
    J Matern Fetal Med; 1998; 7(4):177-82. PubMed ID: 9730483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elimination of infused arginine-vasopressin and its long-acting deaminated analogue in rats.
    Gazis D; Sawyer WH
    J Endocrinol; 1978 Aug; 78(2):179-86. PubMed ID: 702013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Immunocytochemical localization of vasopressin at its absorption by cells of rat small intestine].
    Selivestrova EV; Shakhmatova EI; Komissarchik IaIu; Prutskova NP; Snigirevskaia ES; Natochin IuV
    Tsitologiia; 2004; 46(11):953-9. PubMed ID: 15704875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of radiolabelled quinlukast in rats.
    Syrovatko M; Laznickova A; Laznicek M
    J Pharm Biomed Anal; 2005 Jun; 38(2):313-9. PubMed ID: 15925224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological characterization of arginine vasotocin vascular smooth muscle receptors in the trout (Oncorhynchus mykiss) in vitro.
    Conklin DJ; Smith MP; Olson KR
    Gen Comp Endocrinol; 1999 Apr; 114(1):36-46. PubMed ID: 10094857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro intestinal transport of vasopressin and its analogues.
    Vilhardt H; Lundin S
    Acta Physiol Scand; 1986 Apr; 126(4):601-7. PubMed ID: 3716836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phospholipid mediators and MgATPase modulation causes changes in the cardiovascular effects of vasopressin in lithium carbonate-induced polyuric rats.
    Tyagi MG; Shanthi M; Keshavan V; Vikram GS
    Methods Find Exp Clin Pharmacol; 2004 May; 26(4):257-62. PubMed ID: 15319803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isocratic high-performance liquid chromatography-photodiode-array detection method for determination of lysine- and arginine-vasopressins and oxytocin in biological samples.
    Rao PS; Weinstein GS; Wilson DW; Rujikarn N; Tyras DH
    J Chromatogr; 1991 Jan; 536(1-2):137-42. PubMed ID: 2050761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the first-pass metabolism of ebastine in rats.
    Fujii T; Matsumoto S; Hatoyama T; Miyazaki H
    Arzneimittelforschung; 1997 Aug; 47(8):949-53. PubMed ID: 9296281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1-deamino-/4-valine-8-D-arginine/-vasopressin (dVDAVP), a new synthetic vasopressin analog for treating diabetes insipidus.
    László FA; Czakó L
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):39-43. PubMed ID: 7056603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Position 4 analogues of [deamino-Cys(1)] arginine vasopressin exhibit striking species differences for human and rat V(2)/V(1b) receptor selectivity.
    Guillon G; Pena A; Murat B; Derick S; Trueba M; Ventura MA; Szeto HH; Wo N; Stoev S; Cheng LL; Manning M
    J Pept Sci; 2006 Mar; 12(3):190-8. PubMed ID: 16130178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence of vasopressin in adenohypophysis: research into its role in corticotrope activity.
    Chateau M; Marchetti J; Burlet A; Boulange M
    Neuroendocrinology; 1979; 28(1):25-35. PubMed ID: 431770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of vasopressin and determination of its corticomedullary levels in rat kidney tissue.
    Shimizu K; Nakao A; Nonaka T; Oka H
    Kidney Int; 1984 Dec; 26(6):785-90. PubMed ID: 6533393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of vasopressin, oxytocin, and their analogues in the human gastrointestinal tract.
    Fjellestad-Paulsen A; Söderberg-Ahlm C; Lundin S
    Peptides; 1995; 16(6):1141-7. PubMed ID: 8532599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of antidiuretic and natriuretic effects of [8-lysine]vasopressin and [8-D-arginine]deaminovasopressin in conscious rats.
    Skopková J; Hrbas R; Barth T
    Endocrinol Exp; 1981; 15(2):129-38. PubMed ID: 6973460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Properties of the specific binding site for arginine vasopressin in rat hippocampal synaptic membranes.
    Costantini MG; Pearlmutter AF
    J Biol Chem; 1984 Oct; 259(19):11739-45. PubMed ID: 6480583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasopressin and Its Analogues: From Natural Hormones to Multitasking Peptides.
    Glavaš M; Gitlin-Domagalska A; Dębowski D; Ptaszyńska N; Łęgowska A; Rolka K
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.